Cargando…
Case Report: Human Umbilical Cord Mesenchymal Stem Cells as a Therapeutic Intervention for a Critically Ill COVID-19 Patient
Here we report a critically ill patient who was cured of SARS-CoV-2 infection in Changsha, China. A 66-year-old Chinese woman, with no significant past medical history, developed severe pneumonia-like symptoms and later diagnosed as severe COVID-19 pneumonia. Within 2 months of hospitalization, the...
Autores principales: | Zhang, Quan, Huang, Kang, Lv, Jianlei, Fang, Xiang, He, Jun, Lv, Ailian, Sun, Xuan, Cheng, Lamei, Zhong, Yanjun, Wu, Shangjie, Dai, Yao |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8298026/ https://www.ncbi.nlm.nih.gov/pubmed/34307417 http://dx.doi.org/10.3389/fmed.2021.691329 |
Ejemplares similares
-
Association Between Respiratory Alkalosis and the Prognosis of COVID-19 Patients
por: Wu, Chenfang, et al.
Publicado: (2021) -
Therapeutic prospect on umbilical cord mesenchymal stem cells in animal model with primary ovarian insufficiency: a meta-analysis
por: Wang, Xinrun, et al.
Publicado: (2023) -
Immunomodulatory and Anti-fibrotic Effects Following the Infusion of Umbilical Cord Mesenchymal Stromal Cells in a Critically Ill Patient With COVID-19 Presenting Lung Fibrosis: A Case Report
por: da Silva, Kátia Nunes, et al.
Publicado: (2021) -
Therapeutic Potential of Human Umbilical Cord-Derived Mesenchymal Stem Cells in Recovering From Murine Pulmonary Emphysema Under Cigarette Smoke Exposure
por: Chen, Xiao-Yue, et al.
Publicado: (2021) -
Umbilical Cord Mesenchymal Stem Cells for Inhibiting the Fibrosis and Autoimmune Development in HOCl-Induced Systemic Scleroderma Mouse Model
por: Jin, Xin, et al.
Publicado: (2021)